Quantcast

Posts related to ‘ONXX’

Early Bird Analyst Upgrades & Downgrades (BLL, ONXX, RTP, TEF, ALV, ETEL)

These are some of the early bird analyst calls we are seeing from Wall Street analysts this Thursday morning:Ball Corporation (NYSE: BLL) Raised to Buy at Citigroup.Onyx Pharmaceuticals (NASDAQ: ONXX) ...
Read Full Story »

Select Positive ASCO Data (ARRY, AZN, LLY, DNA, GSK, ONXX, PFE, ZGEN)

Last night was a novel release from the American Society of Clinical Oncology (or ASCO) as the society decided to publish all of the findings to the public at once.  ...
Read Full Story »

As Institutions Sell Millennium On Buyout News, Which Biotech Stocks Will See Inflows? (ALXN, CEPH, CBST, IMCL, ONXX, SEPR, UTHR)

The $8.8 Billion cash buyout of Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM) has created a situation worth monitoring today.  It isn't just that this buyout could create a cascade of other ...
Read Full Story »

Biotech Busine$$ Daily (AMLN, BIIB, CEPH, CYTK, ONXX, REGN, THRX, CBM)

Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look at some notable gainers: Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) up ...
Read Full Story »

Major Biotech Movers (AGEN, CEGE, ENCY, IDMI, IMCL, ONXX, PFE, NTII, OXGN, PSDV, SIRT)

Antigenics Inc.  (NASDAQ: AGEN) A study for Cancer vaccine, Oncophage, for the treatment of metastatic melanoma showed mixed results this morning. Shares are down almost 7% to $2.17. The 52 ...
Read Full Story »

TOP 10 Pre-Market Analyst Calls (CBEY, DHT, GM, IACI, LVLT, NOV, ONXX, PDCO, TWTC, TIVO)

These are not the only analyst calls that are impacting key shares today, but these are the top ten that 24/7 Wall St. is looking at as impact events on ...
Read Full Story »

Pre-Market Analyst Calls (October 2, 2007)

ACAD started as Hold at Citigroup.ALB raised to Neutral at Goldman Sachs.AMB raised to Buy at B of A.APD cut to Neutral at Goldman Sachs.BAC started as Buy at Goldman ...
Read Full Story »

Cramer’s ASCO Biotech Stocks (CELG, ONXX, WMT)

On today's Stop Trading segment on CNBC, Jim Cramer said he was shocked that Revlimid from Celgene (CELG) was hardly noticed and he thinks it's ready to run here.  This ...
Read Full Story »

Cramer’s Three Biotech Picks, And His Biotech Strategy

Stock Tickers: DNA, AMGN, NFLD, CELG, GILD, GENZ, ONXX, DNDNJim Cramer has a video on TheStreet.com "Wall St. Confidential" showing how the biotech sector can be looked at with blow-ups.  ...
Read Full Story »